top of page

ABOUT US

For the past decade, EGG HP investigators and partners have been working to develop new tools, tests, and technologies to help better understand pregnancy and infant health. We strive to put information from these innovations into the hands of women and their healthcare providers everywhere. 

PREGNANCY.
EMPOWERED.

OUR MISSION

TREATING WOMEN AS THEIR OWN BEST HEALTH EXPERTS

We believe that all women (and anyone who is pregnant or trying to get pregnant) deserve the best information possible about their own health, and that with more information comes more empowerment.

​

Our mission is to put as much information as possible into the hands of women and their providers so they can choose what is best for their pregnancy health in partnership.

 

Our focus on information as empowerment continues into early motherhood when we work to help new parents and providers to better understand their own health and that of their baby more deeply.

TEAM EGG HP

We are mothers, fathers, scientists, clinicians, technology experts, and business leaders with a shared commitment to turning knowledge into solutions in partnership with expecting and new mothers, their families, and their healthcare providers.

Laura Jelliffe-Pawlowski, PhD

Founder, CEO

Director of Science and Content

Mike Pawlowski​

Director of Platform and Products

Will Jelliffe

Director of Systems and Applications

Updated EGG Deck Oct 2022 (2)_edited.png
Hello Egg Visualizations (12)_edited.png

Larry Rand, MD

Clinical and Scientific Advisor

Academic Affiliation:

UCSF

Akila Subramaniam, MD

Clinical and Scientific Advisor

Academic Affiliation:

The University of Alabama

Updated EGG Deck Oct 2022 (1)_edited_edited.png

Elizabeth Rogers, MD

Clinical and Scientific Advisor

Academic Affiliation:

UCSF

Updated EGG Deck Oct 2022 (4)_edited.png

Karen Tabb Dina, PhD, MSW

Clinical and Scientific Advisor

Academic Affiliation:

University of Illinois Urbana-Champaign

Updated EGG Deck Oct 2022 (3)_edited.png

 

Kelli Ryckman, PhD

Scientific Advisor

Academic Affiliation:

Indiana University at Bloomington

Updated EGG Deck Oct 2022-35_edited.png

 

Ribka Amsalu, MD

Clinical and Scientific Advisor

Academic Affiliation:

UCSF

Updated EGG Deck Oct 2022 (5)_edited.png

Rebecca Baer, MPH

Scientific Advisor

Academic Affiliation:

UCSF, UCSD

Scott Oltman, MS

Scientific Advisor

Academic Affiliation: UCSF

Safyer McKenzie-Sampson, PhD

Scientific Advisor

Academic Affiliation: 

Stanford University

Kate Monihan

Advisory Board Member

Affiliation: Seva Foundation

Noah Nasser

Advisory Board Member

Affiliation: Datma

Christopher Whitfield

Executive Advisory Board Member

​

Key Moments in Our Journey (So Far)

2015

FIRST RESULTS REPORTED SHOWING THAT MID-PREGNANCY IMMUNE MARKERS CAN BE USED TO PREDICT EARLY SPONTANEOUS PRETERM BIRTH

In 2015 EGG HP experts were some of the first to identify a constellation of mid-pregnancy immune biomarkers that could be used to predict preterm birth. Results were presented at the 2014 Annual meeting of the Society for Maternal and Fetal Medicine. See this first abstract.

2017

BLOOD TEST TO PREDICT PRETERM BIRTH WITH AND WITHOUT PREECLAMPSIA BASED ON IMMUNE MARKERS DEVELOPED: MOVES TO PATENT

In 2017 EGG HP experts first reported on the creation of a prediction test for preterm birth occurring with and without preeclampsia that uses maternal characteristics and immune markers with > 80% accuracy (> 90% for early preterm birth with preeclampsia). Results were published in 2018 in the Journal of Perinatology. Patent filed. See related coverage in WIRED Magazine and on CNN. 

More About Our Founder:
LAURA JELLIFFE-PAWLOWSKI, PHD

As a prominent figure in Epidemiology & Biostatistics and in Public and Global Health Sciences for more than two decades, Dr Laura Jelliffe-Pawlowski has collaborated with experts worldwide to develop valuable tests, tools, and technologies that allow women and health providers to gain a comprehensive understanding of pregnancy health, including crucial insights into potential risks for conditions like preeclampsia and outcomes like preterm birth. Laura's personal experience of being diagnosed with preeclampsia during her own pregnancy left her feeling isolated and uninformed about what was going on with her own body. This powerful journey, coupled with the challenges she faced during delivery and preterm birth complications, fueled her determination to create a women-first platform and community like Egg HP. Laura was a highlighted Innovator on the Forbes 2023 50/50 list.

See a talk from Dr. Laura Jelliffe-Pawlowski, at the 2022 Precision Medicine World Conference: "Pregnancy Health: Women as Their Own Best Experts"

Featured On

bottom of page